Neuroleptic malignant syndrome variant in a patient receiving donepezil and olanzapine

被引：0

作者：

Tanya C Warwick

Venkata Moningi

Prasuna Jami

Kristy Lucas

Ogochukwu Molokwu

Shalini Moningi

机构：

[1] TC Warwick is Assistant Clinical Professor of Neurology at the University of California San Francisco,

[2] Fresno,undefined

[3] CA,undefined

[4] V Moningi is Clinical Assistant Professor of Medicine,undefined

[5] K Lucas is Associate Professor of Pharmacy and Internal Medicine,undefined

[6] and S Moningi is an undergraduate student and Research Assistant at West Virginia University,undefined

[7] Charleston,undefined

[8] WV,undefined

[9] ,undefined

[10] P Jami is an Endocrinology Fellow at the University of Louisville,undefined

[11] KY,undefined

[12] O Molokwu is Assistant Clinical Professor at the School of Pharmacy,undefined

[13] University of California San Francisco,undefined

[14] CA,undefined

[15] USA.,undefined

来源：

Nature Clinical Practice Neurology | 2008年 / 4卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

This Case Study describes a 78-year-old man with a pre-existing parkinsonian syndrome who experienced an adverse drug reaction following administration of an antipsychotic in combination with a cholinesterase inhibitor. The patient was diagnosed with a variant of neuroleptic malignant syndrome.

引用

页码：170 / 174

页数：4

共 50 条

[21] Neuroleptic malignant syndrome associated with olanzapine therapy
Apple, JE
PSYCHOSOMATICS, 1999, 40 (03) : 267 - 268
[22] Olanzapine-Induced Malignant Neuroleptic Syndrome
Saritas, Tuba Berra
Cankaya, Baris
Yosunkaya, Alper
TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION, 2014, 42 (05) : 288 - 291
[23] Neuroleptic Malignant Syndrome With the Addition of Aripiprazole to Olanzapine
Marshall, Phillip B.
Mellman, Thomas A.
Nguyen, Shana Xuanlan C.
AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (11): : 1488 - 1489
[24] NEUROLEPTIC MALIGNANT SYNDROME ASSOCIATED WITH OLANZAPINE THERAPY
Geka, A. -E.
Avgeri, V.
Psarra, V.
Apatangelos, D.
Garnetas, C.
EUROPEAN PSYCHIATRY, 2010, 25
[25] Atypical neuroleptic malignant syndrome caused by olanzapine
Nielsen, J
Bruhn, AM
ACTA PSYCHIATRICA SCANDINAVICA, 2005, 112 (03) : 238 - 240
[26] Olanzapine usage associated with neuroleptic malignant syndrome
Philibert, RA
Adam, LA
Frank, FM
Carney-Doebbeling, C
PSYCHOSOMATICS, 2001, 42 (06) : 528 - 529
[27] Atypical neuroleptic malignant syndrome associated with olanzapine
Reeves, RR
Torres, RA
Liberto, V
Hart, RH
PHARMACOTHERAPY, 2002, 22 (05): : 641 - 644
[28] Neuroleptic malignant syndrome after the initiation of olanzapine
Levenson, JL
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (05) : 477 - 478
[29] Neuroleptic Malignant Syndrome Secondary to Olanzapine Use
Arumairaj, A. J.
Vista, M.
Chaudhari, A.
Lee, S.
Newman, T.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[30] Possible neuroleptic malignant syndrome associated with olanzapine
Nyfort-Hansen, K
Alderman, CP
ANNALS OF PHARMACOTHERAPY, 2000, 34 (05) : 667 - 667

← 1 2 3 4 5 →